Sex, Lies, and Iron Deficiency in 2024: Cost-Effectiveness of Screening Ferritin Thresholds for the Treatment of Iron Deficiency in Women of Reproductive Age
Wang D, Glaeser-Khan S, Wang D, Moshashaian Asl R, Chetlapalli K, Ito S, Cuker A, Goshua G. Sex, Lies, and Iron Deficiency in 2024: Cost-Effectiveness of Screening Ferritin Thresholds for the Treatment of Iron Deficiency in Women of Reproductive Age. Blood 2024, 144: 277-277. DOI: 10.1182/blood-2024-203654.Peer-Reviewed Original ResearchIncremental cost-effectiveness ratioFerritin thresholdIron deficiencyCost-effectiveness ratioIron supplementationNational Health and Nutrition Examination Survey dataUS Medical Expenditure Panel SurveyNutrition Examination Survey dataMedical Expenditure Panel SurveyAverage annual healthcare costsHealth-related well-beingWillingness-to-pay (WTP) thresholdAbsence of universal screeningAnnual healthcare costsWell-being of affected individualsAdult womenStudies of iron statusCost-effective interventionID diagnosisIron dextranTreated with iron supplementationTreatment of iron deficiencyHematologic follow-upOral ferrous sulfateIntravenous iron dextran